Status:

RECRUITING

Posterior Rectus Sheath Hiatal Augmentation in Paraesophageal Hernia Repair

Lead Sponsor:

University of Chicago

Conditions:

Paraesophageal Hernia

Eligibility:

All Genders

18+ years

Brief Summary

This study will be a prospective observation study of the use of PoRSHA for repair in patients with challenging paraesophageal hernias. One of the most challenging problems facing foregut surgeons is...

Detailed Description

One of the most challenging problems facing foregut surgeons is the large and complex paraesophageal hernia (PEH) repair in the older patient. Patients often present for surgery after decades of chron...

Eligibility Criteria

Inclusion

  • All patients undergoing PoRSHA. PoRSHA will be offered to all patients with PEH defects measuring greater than 4 cm.

Exclusion

  • Patients that did not have PoRSHA.
  • Patients requiring therapeutic anticoagulation perioperatively or those with bleeding disorders, considering the added risk of bleeding at the donor site with exposed rectus muscle.

Key Trial Info

Start Date :

May 15 2024

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

May 1 2029

Estimated Enrollment :

100 Patients enrolled

Trial Details

Trial ID

NCT06551077

Start Date

May 15 2024

End Date

May 1 2029

Last Update

September 9 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

The University of Chicago

Chicago, Illinois, United States, 60637